Morozova Ma

2.0k total citations · 1 hit paper
64 papers, 1.5k citations indexed

About

Morozova Ma is a scholar working on Psychiatry and Mental health, Biological Psychiatry and Pharmacology. According to data from OpenAlex, Morozova Ma has authored 64 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Psychiatry and Mental health, 14 papers in Biological Psychiatry and 9 papers in Pharmacology. Recurrent topics in Morozova Ma's work include Schizophrenia research and treatment (27 papers), Bipolar Disorder and Treatment (14 papers) and Tryptophan and brain disorders (14 papers). Morozova Ma is often cited by papers focused on Schizophrenia research and treatment (27 papers), Bipolar Disorder and Treatment (14 papers) and Tryptophan and brain disorders (14 papers). Morozova Ma collaborates with scholars based in Russia, United States and United Kingdom. Morozova Ma's co-authors include David Hough, Pilar Lim, Mariëlle Eerdekens, Srihari Gopal, Ujjwala Vijapurkar, Ferenc Martényi, Darryle D. Schoepp, А С Аведисова, В А Точилов and Bryan G. Johnson and has published in prestigious journals such as Nature Medicine, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Morozova Ma

55 papers receiving 1.5k citations

Hit Papers

Activation of mGlu2/3 receptors as a new approach to trea... 2007 2026 2013 2019 2007 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial
    2007 790 citations Morozova Ma et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Morozova Ma Russia 13 711 628 550 230 184 64 1.5k
Smulevich Ab Russia 11 596 0.8× 517 0.8× 428 0.8× 182 0.8× 153 0.8× 72 1.3k
Nobuhisa Kanahara Japan 24 562 0.8× 903 1.4× 414 0.8× 327 1.4× 318 1.7× 94 2.0k
Don Goff United States 10 471 0.7× 596 0.9× 300 0.5× 161 0.7× 338 1.8× 13 1.3k
Kimberly E. Vanover United States 26 731 1.0× 705 1.1× 619 1.1× 521 2.3× 221 1.2× 67 2.0k
Giovanni Muscettola Italy 26 533 0.7× 562 0.9× 341 0.6× 158 0.7× 224 1.2× 63 1.7k
Stevin H. Zorn United States 20 954 1.3× 662 1.1× 795 1.4× 325 1.4× 114 0.6× 37 2.2k
Elsa M. Valdizán Spain 25 867 1.2× 474 0.8× 366 0.7× 178 0.8× 221 1.2× 57 1.8k
Ede Frecska Hungary 20 539 0.8× 561 0.9× 361 0.7× 290 1.3× 265 1.4× 80 1.8k
Katsura Tottori Japan 16 828 1.2× 1.1k 1.7× 637 1.2× 108 0.5× 160 0.9× 23 2.1k
Hugo A. Jørgensen Norway 25 492 0.7× 828 1.3× 263 0.5× 200 0.9× 385 2.1× 83 1.9k

Countries citing papers authored by Morozova Ma

Since Specialization
Citations

This map shows the geographic impact of Morozova Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morozova Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morozova Ma more than expected).

Fields of papers citing papers by Morozova Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Morozova Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morozova Ma. The network helps show where Morozova Ma may publish in the future.

Co-authorship network of co-authors of Morozova Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Morozova Ma. A scholar is included among the top collaborators of Morozova Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Morozova Ma. Morozova Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ma, Morozova, et al.. (2025). Impulsivity in schizophrenia: phenomenology and research approaches. V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY. 59(2). 20–29.
2.
3.
Ma, Morozova, et al.. (2025). Thermal conductivity, viscosity, and optical properties of nanofluids based on water and carbon nanoparticles. Thermophysics and Aeromechanics. 31(4). 781–790.
4.
Osmolovskaya, Yu. F., et al.. (2024). Cognitive impairment in chronic heart failure. How new therapeutic options for the treatment of chronic heart failure affect cognitive function?. SHILAP Revista de lepidopterología. 100–106. 1 indexed citations
5.
Ma, Morozova, et al.. (2024). Optical properties, thermal conductivity, and viscosity of graphene-based nanofluids for solar collectors. Nano-Structures & Nano-Objects. 40. 101409–101409. 6 indexed citations
6.
7.
Ma, Morozova, et al.. (2023). Validation of the Hospital Anxiety and Depression Scale Russian-language version in the general population. Russian Journal of Preventive Medicine. 26(4). 7–7. 20 indexed citations
8.
9.
Ma, Morozova, et al.. (2022). Low doses of quetiapine (Seroquel) as an impulsivity corrector in patients with bipolar affective disorder in remission. S S Korsakov Journal of Neurology and Psychiatry. 122(8). 120–120. 2 indexed citations
10.
Ивашкин, В. Т., Anna V. Kudryavtseva, George S. Krasnov, et al.. (2022). Efficacy and safety of a food supplement with standardized menthol, limonene, and gingerol content in patients with irritable bowel syndrome: A double-blind, randomized, placebo-controlled trial. PLoS ONE. 17(6). e0263880–e0263880. 8 indexed citations
11.
Ma, Morozova, et al.. (2021). Latent Dysphoria in the Structure of Emotional Disorders in Patients with Functional Constipation. SHILAP Revista de lepidopterología. 10(4). 68–92.
12.
Ivashchenko, Andrey A., Morozova Ma, Alina N. Egorova, et al.. (2021). Safety and efficacy of aviandr in patients with generalized anxiety disorder: A multicenter, randomized, double-blind, placebo-controlled, dose-finding, pilot study. Journal of Psychiatric Research. 143. 436–444. 6 indexed citations
13.
Ma, Morozova, et al.. (2021). Oxidative stress in schizophrenia as a promising target for psychopharmacotherapy. S S Korsakov Journal of Neurology and Psychiatry. 121(9). 131–131. 5 indexed citations
14.
Савушкина, О. К., Е. Б. Терешкина, T. A. Prokhorova, et al.. (2019). Platelet glutamate dehydrogenase activity and efficacy of antipsychotic therapy in patients with schizophrenia. Journal of Medical Biochemistry. 0(0). 54–59. 12 indexed citations
15.
16.
Ma, Morozova, et al.. (2015). Plasma levels of antipsychotics and the severity of side-effects in the treatment of schizophrenia exacerbation. S S Korsakov Journal of Neurology and Psychiatry. 115(11). 40–40. 1 indexed citations
17.
Ma, Morozova, et al.. (2013). Investigation of attitudes toward gambling with implicit association test and self-reported measures. LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas). 2(1). 597–610. 1 indexed citations
18.
19.
Hough, David, Srihari Gopal, Ujjwala Vijapurkar, et al.. (2009). Paliperidone palmitate maintenance treatment in delaying the time-to-relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled study. Schizophrenia Research. 116(2-3). 107–117. 208 indexed citations
20.
Ma, Morozova, et al.. (2000). [A combination of antidepressants and neuroleptics in the treatment of affective disorders and schizophrenia: indications, side effects and complications].. PubMed. 100(11). 60–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Smulevich Ab Breakdown of academic impact, for papers by Nobuhisa Kanahara Breakdown of academic impact, for papers by Don Goff Breakdown of academic impact, for papers by Kimberly E. Vanover Breakdown of academic impact, for papers by Giovanni Muscettola Breakdown of academic impact, for papers by Stevin H. Zorn Breakdown of academic impact, for papers by Elsa M. Valdizán Breakdown of academic impact, for papers by Ede Frecska Breakdown of academic impact, for papers by Katsura Tottori Breakdown of academic impact, for papers by Hugo A. Jørgensen
Rankless by CCL
2026